Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 29;2(4):32. doi: 10.20517/mrr.2023.24

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023.

© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

The microbiota–gut–brain axis in epilepsy. The gut microbiome could affect epilepsy through several mechanisms. For example, an eubiotic microbiota produces metabolites, such as SCFAs and serotonin, which are known to have a possible inhibitory activity on epilepsy occurrence. On the other hand, a dysbiotic layout could be associated with increased gastrointestinal permeability and the production of epilepsy-promoting metabolites, such as proinflammatory factors, which could disrupt the host GABA/glutamate ratio inducing epilepsy events. The interaction between the gut microbiota and the enteric/vagus nervous system, and HPA axis are also potentially involved in the manifestation of epileptic events. BAs: Bile acids; GABA: γ-aminobutyric acid; HPA: hypothalamic-pituitary-adrenal; LPS: lipopolysaccharide; PGN: peptidoglycan; SCFAs: short-chain fatty acids; TMAO: trimethylamine N-oxide.